OUR FOCUS:

Our Focus is on Success at Each Stage of Development

Alphora’s Active Pharmaceutical Ingredient development efforts focus from the pre-clinical stage through to phase III and to the successful technology transfer to manufacturing locations throughout the world.

This focus of development includes:

• Synthetic scale-up development
• Analytical development and validation
• Stability testing
• Gram to kilogram synthesis, both cGMP and non-GMP
• Technology transfer services

Our attention to detail, with our focus to the program's ultimate success, enhances value at each step in the development process.

OUR SERVICES:

Services for Ultimate Success

At whatever stage Alphora services are applied, it is with a view of the long term scale up and commercialization of the Active Pharmaceutical Ingredient. At all stages of development, Alphora will consider issues related to:

• Routes and opportunities for early stage convergence
• Identification of strategic intermediates as candidates for nonGMP outsourcing
• Process optimization
• Raw material costs and commercial sources
• Related compounds and potential impurities
• Final isolations and methods
• Analytical method development and validation
• Specification development
• Stability of the final compound and intermediates